328 related articles for article (PubMed ID: 30513818)
1. Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss.
Simeone P; Liani R; Tripaldi R; Di Castelnuovo A; Guagnano MT; Tartaro A; Bonadonna RC; Federico V; Cipollone F; Consoli A; Santilli F
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513818
[TBL] [Abstract][Full Text] [Related]
2. Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.
Santilli F; Simeone PG; Guagnano MT; Leo M; Maccarone MT; Di Castelnuovo A; Sborgia C; Bonadonna RC; Angelucci E; Federico V; Cianfarani S; Manzoli L; Davì G; Tartaro A; Consoli A
Diabetes Care; 2017 Nov; 40(11):1556-1564. PubMed ID: 28912305
[TBL] [Abstract][Full Text] [Related]
3. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
[TBL] [Abstract][Full Text] [Related]
4. Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus.
Santilli F; Formoso G; Sbraccia P; Averna M; Miccoli R; Di Fulvio P; Ganci A; Pulizzi N; Lattanzio S; Ciabattoni G; Consoli A; Lauro R; Patrono C; Davì G
J Thromb Haemost; 2010 Apr; 8(4):828-37. PubMed ID: 20088941
[TBL] [Abstract][Full Text] [Related]
5. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.
Vazzana N; Guagnano MT; Cuccurullo C; Ferrante E; Lattanzio S; Liani R; Romano M; Davì G
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1726-30. PubMed ID: 22761461
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation in obese women: role of inflammation and oxidant stress.
Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.
Grannes H; Ueland T; Simeone P; Liani R; Guagnano MT; Aukrust P; Michelsen AE; Birkeland K; di Castelnuovo A; Cipollone F; Consoli A; Halvorsen B; Gregersen I; Santilli F
Cardiovasc Diabetol; 2024 Apr; 23(1):146. PubMed ID: 38685051
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis.
Santilli F; Vazzana N; Iodice P; Lattanzio S; Liani R; Bellomo RG; Lessiani G; Perego F; Saggini R; Davì G
Thromb Haemost; 2013 Dec; 110(6):1232-40. PubMed ID: 24030807
[TBL] [Abstract][Full Text] [Related]
10. Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss.
Simeone P; Tripaldi R; Michelsen A; Ueland T; Liani R; Ciotti S; Birkeland KI; Gulseth HL; Di Castelnuovo A; Cipollone F; Aukrust P; Consoli A; Halvorsen B; Santilli F
Cardiovasc Diabetol; 2022 Mar; 21(1):36. PubMed ID: 35277168
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers.
Patrignani P; Panara MR; Tacconelli S; Seta F; Bucciarelli T; Ciabattoni G; Alessandrini P; Mezzetti A; Santini G; Sciulli MG; Cipollone F; Davì G; Gallina P; Bon GB; Patrono C
Circulation; 2000 Aug; 102(5):539-45. PubMed ID: 10920066
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation.
Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.
Dragani A; Falco A; Santilli F; Basili S; Rolandi G; Cerasa L; Lattanzio S; Ciabattoni G; Patrono C; Davì G
Thromb Haemost; 2012 Sep; 108(3):533-42. PubMed ID: 22782530
[TBL] [Abstract][Full Text] [Related]
14. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
[TBL] [Abstract][Full Text] [Related]
15. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
Ferrante E; Vazzana N; Santilli F; Di Cicco M; Lauriti C; Di Battista L; Ciabattoni G; Di Matteo L; Davì G
Free Radic Biol Med; 2010 Sep; 49(5):857-64. PubMed ID: 20541603
[TBL] [Abstract][Full Text] [Related]
16. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
[TBL] [Abstract][Full Text] [Related]
17. In vivo lipid peroxidation and platelet activation in cystic fibrosis.
Ciabattoni G; Davì G; Collura M; Iapichino L; Pardo F; Ganci A; Romagnoli R; Maclouf J; Patrono C
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1195-201. PubMed ID: 11029317
[TBL] [Abstract][Full Text] [Related]
18. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.
Vazzana N; Ganci A; Cefalù AB; Lattanzio S; Noto D; Santoro N; Saggini R; Puccetti L; Averna M; Davì G
J Am Heart Assoc; 2013 Apr; 2(2):e000063. PubMed ID: 23557750
[TBL] [Abstract][Full Text] [Related]
19. Determinants of platelet activation in Alzheimer's disease.
Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
[TBL] [Abstract][Full Text] [Related]
20. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
Minuz P; Patrignani P; Gaino S; Degan M; Menapace L; Tommasoli R; Seta F; Capone ML; Tacconelli S; Palatresi S; Bencini C; Del Vecchio C; Mansueto G; Arosio E; Santonastaso CL; Lechi A; Morganti A; Patrono C
Circulation; 2002 Nov; 106(22):2800-5. PubMed ID: 12451006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
